Literature DB >> 8291748

Methotrexate for urticarial vasculitis.

P S Stack1.   

Abstract

A patient with urticarial vasculitis unresponsive to all treatments except systemic corticosteroids responded completely to low-dose oral methotrexate, allowing withdrawal of corticosteroids. Methotrexate is a proven treatment for other immunologic diseases, and low doses seem to carry an acceptable safety profile. Its use in urticarial vasculitis may be appropriate in selected patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291748

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  2 in total

Review 1.  Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.

Authors:  Kiran Godse; Abhishek De; Vijay Zawar; Bela Shah; Mukesh Girdhar; Murlidhar Rajagopalan; D S Krupashankar
Journal:  Indian J Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.494

Review 2.  Urticarial vasculitis.

Authors:  Stephanie L Gu; Joseph L Jorizzo
Journal:  Int J Womens Dermatol       Date:  2021-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.